Molecular and genetic testing has become a game-changer in brain tumor care - shaping diagnosis, guiding treatments and opening doors to new therapies. Once available to a handful of patients, these ...
(a) Peripheral blood smear in a patient with the chronic phase of chronic myeloid leukemia (CML) before treatment; (b) Detection of BCR::ABL1 fusion gene, p210 by RNA sequencing; (c) Peripheral blood ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...
Jorge Nieva, MD, highlights the critical role of molecular testing in non–small cell lung cancer (NSCLC) care, while addressing barriers such as limited tissue samples, delayed turnaround times, and ...
Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.
Researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital (Duncan NRI) have created a new way to measure genetic variants in the ...
As prenatal genetic testing becomes more common, experts explain what these tests can and cannot predict, how parents should ...
Polymerase Chain Reaction Market To Reach US$31.3Bn By 2033 Persistence Market Research. EINPresswire/ -- The global polymerase chain reaction (PCR) market, integral to molecular diagnostics and life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback